Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $12.5 to $4.
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $12.5 to $4.